Shaily Engineering Plastics Limited · NSE:SHAILY

Shaily Engineering Plastics — Q4 FY25 Earnings Presentation

27 slides from Shaily Engineering Plastics's earnings presentation, May 13, 2025

  1. Slide 1: Exchange filing cover letter for Q4 & FY25 presentation

    SEPL/SE/May/25-26 13th May 2025 The General Manager, The Manager, Corporate Relations/Listing Listing Department Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Floor 25, P.J. Towers, Bandra – Kurla Complex, Dalal Street, Bandra (E), Mumbai – 40

  2. Slide 2: Shaily Engineering Plastics Ltd Investors Presentation May 2025

    Shaily Engineering Plastics Ltd Investors Presentation May 2025

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Shaily Engineering Plastics Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe f

  4. Slide 4: Key Performance Highlights

    Key Performance Highlights

  5. Slide 5: Business Updates for FY25

    Business Updates for FY25 Healthcare Consumer Industrial ✓ Commercial Supplies of pens for GLP-1 drug ‘Semaglutide’ will ✓ 2 new products added in plastics and 3 new ✓ New Business Confirmation: start in FY26 products added in carbon steel with home Business awarded from new furnishing customer in Q

  6. Slide 6: Continued Growth Momentum across FY25: Revenues and Gross Profit

    Continued Growth Momentum across FY25 (Consolidated*) Revenues Gross Profit & GP Margins 42.1% 46.3% 47.5% 51.7% +10% +20% +7% +3% 217.8 +18% +6% 112.6 192.0 197.6 179.4 89.0 93.9 75.5 Q1FY25 Q2FY25 Q3FY25 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY25 Highest ever Revenues & Profitability recorded in FY25 This

  7. Slide 7: Continued Growth Momentum across FY25: EBITDA and PAT

    Continued Growth Momentum across FY25 (Consolidated*) EBITDA & EBITDA Margins Profit After Tax & PAT Margins 20.1% 21.5% 23.4% 25.1% 9.7% 11.4% 12.8% 13.1% +18% +13% +12% +15% +14% 54.6 +26% 28.6 46.3 25.2 41.3 21.9 36.1 17.4 Q1FY25 Q2FY25 Q3FY25 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY25 Highest ever Reven

  8. Slide 8: Segment Wise Revenue Breakup

    Segment Wise Revenue Breakup Consumer Segment Healthcare Segment +4% +2% +5% +28% +17% 148.1 +36% 56.0 132.8 138.6 141.3 43.7 37.4 27.4 Q1FY25 Q2FY25 Q3FY25 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY25 Industrial Segment Total Revenue +3% +10% -16% +7% -22% +9% 19.2 197.6 217.8 16.0 179.4 192.0 12.5 13.7 Q1FY

  9. Slide 9: Key Financial Highlights – Q4 & FY25 (Consolidated)

    Key Financial Highlights – Q4 & FY25 (Consolidated*) Revenues Gross Profit Margin EBITDA +490 bps +470 bps +28% +22% +51% +45% 217.8 786.8 51.7% 47.2% 54.6 178.4 643.9 46.8% 42.5% 170.6 36.3 123.4 Q4FY24 Q4FY25 FY24 FY25 Q4FY24 Q4FY25 FY24 FY25 Q4FY24 Q4FY25 FY24 FY25 EBITDA Margins Profit After Tax

  10. Slide 10: Q4 FY25 Segment Wise Revenue Breakup

    Segment Wise Revenue Breakup Revenue (Consumer) Revenue (Healthcare) Revenue (Industrial) TOTAL REVENUE +27% +45% +28% -10% Q4 FY25 148.1 56.0 15.2 217.8 13.7 116.7 170.6 38.6 Q4FY24 Q4FY25 Q4FY24 Q4FY25 Q4FY24 Q4FY25 Q4FY24 Q4FY25 Revenue (Consumer) Revenue (Healthcare) Revenue (Industrial) TOTAL R

  11. Slide 11: Key Financial Highlights – Q4 & FY25 (Standalone)

    Key Financial Highlights – Q4 & FY25 (Standalone) Revenues Gross Profit Margin EBITDA +410 bps +380 bps +25% +20% +76% +49% 203.3 738.1 44.2% 48.3% 39.9% 43.7% 52.4 151.0 162.8 616.0 101.3 29.8 Q4FY24 Q4FY25 FY24 FY25 Q4FY24 Q4FY25 FY24 FY25 Q4FY24 Q4FY25 FY24 FY25 EBITDA Margins Profit After Tax Ca

  12. Slide 12: Operational Trends

    Operational Trends +416 bps +210 bps Revenue Analysis – Domestic vs. Exports Machine Utilization 44.0% 42.2% Across Plants (%) 39.8% 40.1% Q4 FY24 vs Q4 FY25 26.9% 20.1% Q4FY24 Q4FY25 FY24 FY25 73.1% 79.9% +21% +13% Volume of Polymers 6,536 24,932 FY24 vs FY25 Processed (MT) 22,098 5,380 26.1% 22.2%

  13. Slide 13: Efficient Use of Capital

    Efficient Use of Capital RoCE RoE Fixed Asset Turnover Total Debt / Equity +670 bps +520 bps 24.4% 18.5% 1.71 0.5 1.48 17.7% 13.3% 0.4 Mar-24 Mar-25 Mar-24 Mar-25 Mar-24 Mar-25 Mar-24 Mar-25 On Consolidated Basis 12

  14. Slide 14: Profit & Loss Statement

    Profit & Loss Statement Consolidated Standalone Particulars (Rs. Cr.) Q4 FY25 Q4 FY24 YoY % FY25 FY24 YoY % Q4 FY25 Q4 FY24 YoY % FY25 FY24 YoY % Revenue 217.8 170.6 28% 786.8 643.9 22% 203.3 162.8 25% 738.1 616.0 20% Raw Material 105.2 90.8 415.8 370.1 105.2 90.8 415.7 370.1 Employee Expenses 23.2

  15. Slide 15: Balance Sheet (Consolidated)

    Balance Sheet Particulars (Rs. Crs.) Mar-25 Mar-24 Particulars (Rs. Crs.) Mar-25 Mar-24 Non-Current assets Equity Property, Plant and Equipments 459.1 435.4 Equity Share Capital 9.2 9.2 Capital Work in Process 17.4 15.3 Other Equity 538.5 450.0 Intangible assets 42.1 38.0 Total Equity 547.7 459.2 In

  16. Slide 16: Balance Sheet (Standalone)

    Balance Sheet Particulars Mar-25 Mar-24 Particulars Mar-25 Mar-24 Non-Current assets Equity Property, Plant and Equipments 457.6 434.9 Equity Share Capital 9.2 9.2 Capital Work in Process 17.4 15.3 Other Equity 487.0 422.3 Intangible assets 19.5 17.8 Total Equity 496.2 431.5 Investments 11.3 20.6 No

  17. Slide 17: Cash Flow Statement

    Cash Flow Statement Consolidated Standalone Particulars (Rs. Cr.) FY25 FY24 FY25 FY24 Profit Before Tax 119.3 69.8 94.7 48.7 Adjustments 56.6 58.2 46.6 56.2 Operating profit before working capital changes 175.9 128.0 141.3 104.8 Changes in working capital -48.3 -27.0 -30.5 -21.6 Cash generated from

  18. Slide 18: About the Company

    About the Company Enriching Lives Through Plastics Shaily Engineering Plastics Limited is India’s largest exporter of plastics components. Established in 1987, the Company provides end-to-end solutions in plastic products and services, whilst delivering superior quality and value to all stakeholders

  19. Slide 19: Business Segments

    Business Segments Consumer Industrial Healthcare ✓ Automotive Components ✓ LED Lights ✓ Platform Devices ✓ Home Furnishings ✓ Appliances ✓ Toys ✓ Drug Delivery Devices ✓ FMCG Packaging ✓ High Performance ✓ Carbon Steel Furniture ✓ Pharma Packaging Engineering Components 18

  20. Slide 20: State-of-the-Art Manufacturing Facilities

    State-of-the-Art Manufacturing Facilities 7 Facilities with over 200 molding machines ranging from 35 tons to 1,000 tons Rania ❖ Export Oriented Unit ❖ Pharma (Dedicated ISO Class 8 clean room manufacturing facility) ❖ Others Rania Halol GUJARAT Halol (GIDC) ❖ Automotive & Engineering Halol ❖ Carbon

  21. Slide 21: Board of Directors

    Board of Directors Executive Chairman Whole Time Director Managing Director Mr. Mahendra Sanghvi Ms. Tilottama Sanghvi Mr. Amit Sanghvi Independent Director Executive Director Independent Director Dr. Shailesh Ayyangar Mr. Ranjit Singh Mr. Laxman Sanghvi Independent Director Independent Director Mr.

  22. Slide 22: Strong Credit Rating

    Strong Credit Rating* Long and established track record in the plastic injection LONG TERM BANK FACILITIES molding business along with experienced Promoters Rs. 238.45 Crs. Growth in Total operating income on the back of CARE A+ ; Outlook: Stable increased volumes & higher exports Rating Action: Upg

  23. Slide 23: Historical Profit & Loss Statement

    Historical Profit & Loss Statement Consolidated Standalone Particulars (Rs. Cr.) FY25 FY24 FY23 FY25 FY24 FY23 Revenue 786.8 643.9 607.1 738.1 616.0 599.7 Raw Material 415.8 370.1 386.5 415.7 370.1 386.5 Employee Expenses 80.4 57.3 47.9 72.8 55.9 47.2 Other Expenses* 114.5 99.5 80.8 106.0 95.2 79.4

  24. Slide 24: Historical Balance Sheet (Consolidated)

    Historical Balance Sheet Particulars Mar-25 Mar-24 Mar-23 Particulars Mar-25 Mar-24 Mar-23 Non-Current assets Equity Property, Plant and Equipments 459.1 435.4 347.9 Equity Share Capital 9.2 9.2 9.2 Capital Work in Process 17.4 15.3 49.0 Other Equity 538.5 450.0 392.2 Intangible assets 42.1 38.0 19.

  25. Slide 25: Historical Balance Sheet (Standalone)

    Historical Balance Sheet Particulars Mar-25 Mar-24 Mar-23 Particulars Mar-25 Mar-24 Mar-23 Non-Current assets Equity Property, Plant and Equipments 457.6 434.9 348.6 Equity Share Capital 9.2 9.2 9.2 Capital Work in Process 17.4 15.3 49.0 Other Equity 487.0 422.3 386.5 Intangible assets 19.5 17.8 13.

  26. Slide 26: Cash Flow Statement

    Cash Flow Statement Consolidated Standalone Particulars (Rs. Cr.) FY25 FY24 FY23 FY25 FY24 FY23 Profit Before Tax 119.3 69.8 45.2 94.7 48.7 40.1 Adjustments 56.6 58.2 51.4 46.6 56.2 50.4 Operating profit before working capital changes 175.9 128.0 96.6 141.3 104.8 90.5 Changes in working capital -48.

  27. Slide 27: Contact

    Contact Company : Investor Relations Advisors : Shaily Engineering Plastics Ltd. Strategic Growth Advisors Pvt. Ltd. CIN – L51900GJ1980PLC065554 CIN - U74140MH2010PTC204285 Mr. Sanjay Shah, Chief Strategy Officer Mr. Shogun Jain / Mr. Deven Dhruva sanjay@shaily.com shogun.jain@sgapl.net / deven.dhru

Shaily Engineering Plastics — Q4 FY25 Earnings Presentation on 6ix